John T. Parissis
#153,666
Most Influential Person Now
John T. Parissis's AcademicInfluence.com Rankings
John T. Parissismedical Degrees
Medical
#2982
World Rank
#3431
Historical Rank
Cardiology
#300
World Rank
#306
Historical Rank
John T. Parissisphilosophy Degrees
Philosophy
#8602
World Rank
#12012
Historical Rank
Logic
#5635
World Rank
#7047
Historical Rank
Download Badge
Medical Philosophy
Why Is John T. Parissis Influential?
(Suggest an Edit or Addition)John T. Parissis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. (2016) (7627)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016) (6692)
- 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. (2016) (5626)
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2010) (4824)
- EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) (2013) (694)
- Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry (2017) (475)
- Clinical picture and risk prediction of short‐term mortality in cardiogenic shock (2015) (457)
- Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. (2001) (418)
- Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology (2016) (395)
- EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) (2010) (395)
- Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. (2002) (287)
- Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. (2012) (266)
- Insights into onco-cardiology: atrial fibrillation in cancer. (2014) (261)
- Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2017) (231)
- Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) (2011) (228)
- Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. (2013) (224)
- Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods (2011) (213)
- Reframing the association and significance of co‐morbidities in heart failure (2016) (181)
- Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. (2004) (175)
- Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology (2020) (155)
- Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality (2016) (141)
- A glossary of circulating cytokines in chronic heart failure (2001) (140)
- Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis (2014) (129)
- Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. (2006) (127)
- The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations. (2015) (124)
- Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. (2004) (118)
- Blood Pressure Reduction and Secondary Stroke Prevention: A Systematic Review and Metaregression Analysis of Randomized Clinical Trials (2017) (113)
- Effects of levosimendan on right ventricular function in patients with advanced heart failure. (2006) (111)
- Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure. (2005) (109)
- Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. (2016) (101)
- Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure (2006) (96)
- Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. (2014) (95)
- Acute heart failure: Epidemiology, risk factors, and prevention. (2015) (95)
- Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial (2014) (95)
- Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. (2002) (93)
- Classical inotropes and new cardiac enhancers (2007) (93)
- Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (2008) (90)
- Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. (2002) (90)
- Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes (2018) (89)
- Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study (2008) (87)
- Levosimendan meta-analyses: Is there a pattern in the effect on mortality? (2016) (86)
- Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta‐analysis (2016) (84)
- Global left atrial failure in heart failure (2016) (84)
- Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. (2003) (83)
- Functional electrical stimulation improves endothelial function and reduces peripheral immune responses in patients with chronic heart failure (2006) (83)
- Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications. (2007) (80)
- Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2018) (75)
- Renal Effects of Levosimendan: A Consensus Report (2013) (74)
- Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups (2013) (72)
- The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation. (2009) (72)
- Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients. (2004) (70)
- Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. (2004) (69)
- Recurrent Stroke and Patent Foramen Ovale: A Systematic Review and Meta-Analysis (2014) (67)
- Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. (1995) (67)
- Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure (2018) (66)
- Electronic Cigarette Smoking Increases Arterial Stiffness and Oxidative Stress to a Lesser Extent Than a Single Conventional Cigarette: An Acute and Chronic Study. (2018) (66)
- Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus. (2014) (66)
- Self‐assessment of health status is associated with inflammatory activation and predicts long‐term outcomes in chronic heart failure (2009) (65)
- Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease (2014) (65)
- Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure. (2007) (63)
- Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure (2007) (62)
- Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment (2020) (61)
- The value of transesophageal echocardiography for embolic strokes of undetermined source (2016) (61)
- Impact of diuretic dosing on mortality in acute heart failure using a propensity‐matched analysis (2011) (60)
- Association of impaired left ventricular twisting‐untwisting with vascular dysfunction, neurohumoral activation and impaired exercise capacity in hypertensive heart disease (2015) (59)
- Acute pulmonary oedema: clinical characteristics, prognostic factors, and in‐hospital management (2010) (56)
- Renal dysfunction and heart failure: things are seldom what they seem. (2014) (55)
- Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome (2017) (55)
- Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. (2006) (53)
- Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. (2010) (53)
- Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation. (2015) (53)
- Levosimendan: from basic science to clinical practice (2009) (53)
- Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis (2017) (53)
- Inflammatory markers in coronary artery disease (2012) (53)
- Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. (2012) (52)
- Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure. (2008) (52)
- Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality (2018) (52)
- Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches (2005) (51)
- Functional electrical stimulation of peripheral muscles improves endothelial function and clinical and emotional status in heart failure patients with preserved left ventricular ejection fraction. (2013) (51)
- Complex Atheromatous Plaques in the Descending Aorta and the Risk of Stroke: A Systematic Review and Meta-Analysis (2014) (51)
- Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. (2002) (50)
- Overview of emerging pharmacologic agents for acute heart failure syndromes (2008) (49)
- Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage (2017) (49)
- Inotropes in cardiac patients: update 2011 (2010) (48)
- Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure (2008) (48)
- Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. (2014) (48)
- Heart Failure Association of the European Society of Cardiology Specialist Heart Failure Curriculum (2014) (47)
- Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (2009) (47)
- Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock (2017) (46)
- Functional electrical stimulation is more effective in severe symptomatic heart failure patients and improves their adherence to rehabilitation programs. (2010) (46)
- Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure. (2008) (45)
- Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules. (2010) (45)
- Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application (2018) (45)
- Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia. (2000) (44)
- Plasma levels of soluble cellular adhesion molecules in patients with arterial hypertension. Correlations with plasma endothelin-1. (2001) (44)
- Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis. (2019) (43)
- Effects of functional electrical stimulation on quality of life and emotional stress in patients with chronic heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy: A randomised, placebo‐controlled trial (2008) (42)
- Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives (2018) (42)
- Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure (2014) (41)
- Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study (2017) (41)
- Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. (2003) (41)
- Understanding acute heart failure: pathophysiology and diagnosis (2016) (40)
- Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction. (2011) (40)
- Plasma B‐type natriuretic peptide and anti‐inflammatory cytokine interleukin‐10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1‐year follow‐up study (2009) (40)
- Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology (2020) (40)
- Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study. (2009) (40)
- Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes (2019) (39)
- New aspects for the role of physical training in the management of patients with chronic heart failure. (2003) (39)
- Gender-related differences in patients with acute heart failure: management and predictors of in-hospital mortality. (2013) (38)
- Hyponatremia in heart failure (2008) (38)
- Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. (2017) (37)
- The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock - Results from the CardShock Study. (2017) (36)
- Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem. (1995) (36)
- Levosimendan for the treatment of acute heart failure syndromes (2005) (36)
- Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (2010) (35)
- A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus. (2019) (35)
- Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure. (2013) (35)
- Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure (2007) (35)
- The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta‐analysis (2016) (35)
- Determinants of the direct cost of heart failure hospitalization in a public tertiary hospital. (2015) (34)
- Prognostic value of high sensitivity troponin T in patients with acutely decompensated heart failure and non-detectable conventional troponin T levels. (2013) (34)
- Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications (2017) (34)
- The Cardio-Renal Interrelationship. (2017) (34)
- Heart failure diagnosis and prognosis in the elderly: the proof of the pudding is in the eating (2011) (34)
- Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart. (2005) (34)
- The role of left ventricular long-axis contraction in patients with asymptomatic aortic regurgitation. (2006) (33)
- Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study. (2017) (33)
- Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study. (2011) (32)
- Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity (2014) (32)
- Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function (2019) (32)
- Heart failure and the risk of ischemic stroke recurrence: A systematic review and meta-analysis (2016) (32)
- Heart failure and sepsis: practical recommendations for the optimal management (2019) (31)
- In-hospital management of acute heart failure: Practical recommendations and future perspectives. (2015) (31)
- Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19 (2020) (31)
- Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (2009) (31)
- Correlation of interleukin-6 gene expression to immunologic features in patients with cardiac myxomas. (1996) (30)
- Use of levosimendan in acute heart failure (2018) (30)
- Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use (2020) (30)
- Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers (2020) (29)
- Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice (2015) (29)
- The association of adult vaccination with the risk of cerebrovascular ischemia: A systematic review and meta-analysis (2018) (29)
- Therapeutic Options for the Management of the Cardiorenal Syndrome (2010) (28)
- Oral anticoagulation in patients with chronic kidney disease (2019) (28)
- Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis (2016) (28)
- Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease. (2014) (27)
- Percutaneous patent foramen ovale closure for secondary stroke prevention (2018) (27)
- Body mass index in acute heart failure: association with clinical profile, therapeutic management and in‐hospital outcome (2016) (27)
- Novel biologic mechanisms of levosimendan and its effect on the failing heart (2008) (27)
- Depressive Symptoms in Patients with Congenital Heart Disease: Incidence and Prognostic Value of Self-Rating Depression Scales. (2015) (26)
- Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage. (2017) (25)
- Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates (2016) (25)
- Pulse wave velocity to global longitudinal strain ratio in hypertension (2019) (25)
- Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications. (2002) (25)
- Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome (2017) (24)
- Rationale and design of the multicentre randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study) (2010) (24)
- Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology-Heart Failure pilot survey. (2014) (24)
- Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction. (2004) (24)
- The evaluation of pulse wave velocity using Arteriograph and Complior apparatus across multiple cohorts of cardiovascular-related diseases. (2013) (24)
- Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. (2010) (23)
- Pulse wave analysis using the Mobil-O-Graph, Arteriograph and Complior device: a comparative study (2019) (23)
- Effects of Levosimendan on Quality of Life and Emotional Stress in Advanced Heart Failure Patients (2007) (23)
- Altered mental status predicts mortality in cardiogenic shock – results from the CardShock study (2018) (23)
- Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure (2013) (23)
- Loss of heterozygosity in DNA mismatch repair genes in human atherosclerotic plaques. (2000) (23)
- Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock (2019) (23)
- Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice (2019) (23)
- Insulin resistance and acute glucose changes determine arterial elastic properties and coronary flow reserve in dysglycaemic and first-degree relatives of diabetic patients. (2015) (22)
- Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches (2012) (22)
- Pharmaco-economics of levosimendan in cardiology: a European perspective. (2015) (22)
- Incremental predictive value of carotid intima–media thickness to arterial stiffness for impaired coronary flow reserve in untreated hypertensives (2010) (22)
- Ventricular long-axis contraction as an earlier predictor of outcome in asymptomatic aortic regurgitation. (2007) (22)
- Left ventricular geometry as a major determinant of left ventricular ejection fraction: physiological considerations and clinical implications (2018) (21)
- Novel biologic mechanisms of levosimendan and its effect on the failing heart. (2008) (21)
- Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (2000) (21)
- Efficacy and safety of functional electrical stimulation of lower limb muscles in elderly patients with chronic heart failure: A pilot study (2015) (21)
- Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4‐year follow‐up study (2017) (21)
- Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process (2017) (21)
- Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow–Up Study (2019) (20)
- Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm (2015) (20)
- A simple score for early risk stratification in acute heart failure. (2017) (20)
- Association of abnormal coronary microcirculatory function with impaired response of longitudinal left ventricular function during adenosine stress echocardiography in untreated hypertensive patients. (2012) (19)
- MitraClip and left ventricular reverse remodelling: a strain imaging study (2020) (19)
- Acute Heart Failure Syndromes in the Elderly: The European Perspective. (2015) (19)
- Tumor Necrosis Factor-a Serum Activity During Treatment of Acute Decompensation of Cachectic and Non-Cachectic Patients with Advanced Congestive Heart Failure (1999) (19)
- The role of lipoprotein-associated phospholipase A2 (Lp-PLA₂) in cardiovascular disease. (2011) (19)
- Left ventricular ejection fraction as therapeutic target: is it the ideal marker? (2017) (18)
- Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use (2020) (18)
- Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: evidence for pleiotropic effects. (2006) (18)
- Selenium contributes to myocardial injury and cardiac remodeling in heart failure. (2014) (18)
- Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure (2017) (18)
- Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care (2018) (18)
- Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure (2012) (18)
- Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy (2005) (18)
- Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing (2018) (18)
- Coronary flow reserve is associated with tissue ischemia and is an additive predictor of intensive care unit mortality to traditional risk scores in septic shock. (2014) (18)
- Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia. (2005) (17)
- Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra (2011) (17)
- Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non‐randomized, open‐label, proof‐of‐concept study (2021) (17)
- Sertraline for the treatment of depression in coronary artery disease and heart failure (2007) (17)
- Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke (2020) (17)
- Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors (2018) (16)
- Cytokines and anti-cytokine therapeutic approaches to chronic heart failure. (2002) (16)
- Acute heart failure: lessons learned, roads ahead (2018) (16)
- Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline? (2019) (16)
- The role of left ventricular long axis contraction in patients with asymptomatic non-ischemic mitral valve regurgitation and normal systolic function. (2008) (16)
- Chemokines in cardiovascular remodeling: clinical and therapeutic implications. (2003) (15)
- Impaired Arterial Elastic Properties and Endothelial Glycocalyx in Patients with Embolic Stroke of Undetermined Source (2019) (15)
- An atypical left atrial myxoma causing intracavitary pressure gradient and typical diastolic transmitral flow of severe mitral stenosis. (2005) (15)
- Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study (2021) (15)
- Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan (2019) (15)
- Prognostic value of in-hospital change in cystatin C in patients with acutely decompensated heart failure and renal dysfunction. (2015) (15)
- The effect of acute administration of statins on coronary microcirculation during the pre-revascularization period in patients with myocardial infraction. (2012) (14)
- Well‐functioning double‐orifice mitral valve in a young adult (2003) (14)
- Anticoagulants, antiplatelets, and statins in heart failure. (2008) (14)
- Association of arterial stiffness with coronary flow reserve in revascularized coronary artery disease patients. (2016) (14)
- Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure. (1999) (14)
- Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients (2015) (14)
- Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients. (2007) (14)
- Detection of microsatellite instability in sporadic cardiac myxomas. (1999) (14)
- Optimal Blood Pressure Control Improves Left Ventricular Torsional Deformation and Vascular Function in Newly Diagnosed Hypertensives: a 3-Year Follow-up Study (2020) (13)
- Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity. (2003) (13)
- Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3. (2004) (13)
- Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience. (2016) (13)
- Cardiogenic shock in cancer (2019) (13)
- Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation. (2019) (13)
- Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock. (2017) (13)
- Imaging Risk in Multisystem Inflammatory Diseases. (2019) (12)
- Inotropes for the management of acute heart failure patients with renal dysfunction. Still an option? (2012) (12)
- Cardiac imaging in cardiotoxicity: a focus on clinical practice (2020) (12)
- The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19) (2020) (12)
- Hematopoietic colony stimulating factors in cardiovascular and pulmonary remodeling: promoters or inhibitors? (2006) (12)
- Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure (2017) (11)
- Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment (2017) (11)
- Measurement of central augmentation index by three different methods and techniques: Agreement among Arteriograph, Complior, and Mobil‐O‐Graph devices (2019) (10)
- Immunosenescence in patients with chronic systolic heart failure (2016) (10)
- Current drugs and medical treatment algorithms in the management of acute decompensated heart failure. (2009) (10)
- Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes (2008) (10)
- Current drugs and medical treatment algorithms in the management of acute decompensated heart failure (2009) (10)
- Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6-Year Follow-up Study (2021) (10)
- Congenital left ventricular aneurysm: a cause of impaired myocardial torsion and peripheral thrombo-embolic events. (2011) (10)
- Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients with Cardiogenic Shock - Results from The Cardshock Study. (2019) (10)
- Exhaled breath condensate in acute and chronic heart failure: new insights into the role of lung injury and barrier dysfunction. (2014) (9)
- Giant unruptured aneurysm of right valsalva sinus detected by magnetic resonance imaging. (2004) (9)
- Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure (2016) (9)
- Medical management of stable angina. (2014) (9)
- Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications (2017) (9)
- The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit–risk ratio (2015) (9)
- Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes (2021) (9)
- How to develop a national heart failure clinics network: a consensus document of the Hellenic Heart Failure Association (2020) (9)
- Acutely decompensated versus acute heart failure: two different entities (2019) (9)
- Severe anaemia and subcapital femur fracture in a patient with Left Ventricular Assist Device Heart Mate II: the cardiologist's management of this rare patient (2009) (9)
- Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study (2021) (9)
- Novel biomarkers in acute coronary syndromes: new molecules, new concepts, but what about new treatment strategies? (2014) (9)
- Telephone based survey in adults with congenital heart disease during COVID-19 pandemic. (2020) (8)
- Duration of paroxysmal atrial fibrillation in cryptogenic stroke is not associated with stroke severity and early outcomes (2017) (8)
- Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention. (2013) (8)
- Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure. (2008) (8)
- Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department. (2009) (8)
- Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock (2021) (8)
- Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma. (1995) (8)
- Cardiovascular Diseases and Hemodialysis: Novel Strategies for Diagnosis, Prevention and Treatment (2003) (8)
- Potential Utility of Neurosonology in Paroxysmal Atrial Fibrillation Detection in Patients with Cryptogenic Stroke (2019) (8)
- Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy? (2008) (8)
- β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease (2020) (7)
- Treating depression in coronary artery disease and chronic heart failure: what's new in using selective serotonin re-uptake inhibitors? (2012) (7)
- Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis (2021) (7)
- Differential effects of inotropes and inodilators on renal function in acute cardiac care (2020) (7)
- Differential effects of heat-not-burn and conventional cigarettes on coronary flow, myocardial and vascular function (2020) (7)
- Clinical and prognostic implications of plasma NGAL and NT-proBNP in adult patients with congenital heart disease. (2014) (7)
- Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure. (2012) (7)
- Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure (2018) (7)
- The interplay between renin-angiotensin system activation, abnormal myocardial deformation and neurohumoral activation in hypertensive heart disease: a speckle tracking echocardiography study (2017) (7)
- 263 Classifying patients with acute heart failure: Presentation treatment and outcome. A ten country survey of acute heart failure management (ALARM‐HF) (2008) (7)
- Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment. (2007) (7)
- Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. (2014) (7)
- A rare case of large mediastinal germ cell tumor detected by echocardiography. (2005) (6)
- Plasma activity of B-type natriuretic peptide in patients with biventricular heart failure versus those with right heart failure due to chronic obstructive pulmonary disease (2014) (6)
- New insight into "heart-hand" syndromes: a newly discovered chromosomal abnormality in a family with "heart-hand" syndrome. (2004) (6)
- A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia. (2018) (6)
- Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations (2021) (6)
- 491 Effects of intravenous levosimendan and dobutamine on circulating pro‐inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure (2004) (6)
- Tissue Doppler Imaging Analysis at Pre‐Cardioversion Time Predicts Recurrent Atrial Fibrillation: A 12‐Month Follow‐Up Study (2006) (6)
- Ups and downs in heart failure: the case of proteomics (2018) (6)
- Dobutamine-induced changes of multidimensional cardiac deformation predict functional capacity in patients with advanced systolic heart failure. (2014) (5)
- Structured discharge instructions for hospitalized heart failure patients to improve guideline implementation and patient outcomes. (2016) (5)
- 733 Effects of Darbepoetin-alpha on Plasma Pro-inflammatory Cytokines and Soluble Fas/Fas Ligand System in Anemic Patients with Chronic Heart Failure (2008) (5)
- 18F‐FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic heart failure patients with impaired systolic function (2020) (5)
- Prognostic significance of global longitudinal strain in chronic kidney disease: the evidence is building (2018) (5)
- The Model for End‐stage Liver Disease score in acute heart failure: hepatorenal dysfunction hides behind (2016) (5)
- Sunday, 26 August 2012 (2012) (5)
- Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function (2011) (5)
- Heart failure in the course of a pandemic (2020) (4)
- A primary cardiac leiomyosarcoma with mutation at H-ras codon 12. (1997) (4)
- Distribution, infrastructure, and expertise of heart failure and cardio‐oncology clinics in a developing network: temporal evolution and challenges during the coronavirus disease 2019 pandemic (2020) (4)
- Proinflammatory Cytokines and Peripheral Myopathy in Patients with Chronic Heart Failure: The Beneficial Effect of Physical Exercise (2004) (4)
- Clinical correlates and prognostic value of apoptosis mediator soluble forms in patients with congestive heart failure (1998) (4)
- Practical recommendations for the diagnosis and medical management of stable angina: An expert panel consensus. (2019) (4)
- Left ventricular assist device vegetation: "cure" without device explantation. (2010) (4)
- Non-obstructive left ventricular assist device outflow thrombus: What is the appropriate management? (2016) (4)
- Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study. (2020) (4)
- P3340Greater improvement of coronary artery function, left ventricular deformation and twisting by treatment with IL-17A antagonist compared to Cyclosporine in psoriasis (2017) (4)
- Overcoming the ethnic differences in patients hospitalized for heart failure: is there a need for international harmonization of clinical practice guidelines? (2015) (4)
- Guiding decongestion treatment in chronic heart failure patients. Clinical assessment or serial laboratory evaluation (2013) (4)
- Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock (2020) (3)
- Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease (2020) (3)
- Blood Pressure Reduction and Secondary Stroke Prevention (2016) (3)
- Levosimendan in viral myocarditis: not only an inodilator but also a cardioprotector? (2009) (3)
- Vaccination in Heart Failure: An Approach to Improve Outcomes. (2018) (3)
- Levosimendan therapy in decompensated chronic heart failure: Favourable haemodynamic and neurohormonal effects but for how long? (2006) (3)
- Monday, 27 August 2012 (2012) (3)
- Inotropic agents in cardiogenic shock. (2020) (2)
- Implantable devices to monitor patients with heart failure (2018) (2)
- Association of impaired arterial wall properties with the presence of coronary artery disease in patients with abdominal aortic aneurysms (2020) (2)
- Natriuretic peptides in acute coronary syndromes: A new role to predict recurrent ischemic event-related mortality? (2018) (2)
- Immunomodulatory Effects of Physical Training in Chronic Heart Failure (2003) (2)
- It’s Not All about Echocardiography. Open the Lung Window for the Cardiac Emergencies (2021) (2)
- When and How to Use Inotropes (2018) (2)
- 279Inhibition of Interleukin-6 activity by tocilizumab improves arterial stiffness, LV myocardial deformation and endothelial glycocalyx in patients with rheumatoid arthritis (2017) (2)
- Heart failure/transplant abstractPhysical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure☆ (2002) (2)
- Chitinase-3-like protein-1 (YKL-40) before and after therapy in supraventricular arrhythmias (2017) (2)
- Endothelial glycocalyx and microvascular perfusion are associated with carotid intima-media thickness and impaired myocardial deformation in psoriatic disease (2021) (2)
- Syncope in a patient with tortuous right common carotid artery. (2017) (2)
- The prognostic role of echocardiographic indices in chronic heart failure: right ventricle revisited (2009) (2)
- Physical training reduces circulating monocyte‐endothelial cell adhesive interaction markers in patients with chronic heart failure (2000) (2)
- Natriuretic peptides revisited: new potentials and challenges in heart failure. (2016) (2)
- Rapid normalization of vasculitis-induced left ventricular dysfunction related with multiple cardiac thrombi (2015) (2)
- Risk in atrial fibrillation: left atrial function matters (2019) (1)
- Fagerstrom score predicts smoking status six months after hospitalization for acute myocardial infarction: a prospective study. (2022) (1)
- SIMILARITIES IN CORONARY FUNCTION AND MYOCARDIAL DEFORMATION BETWEEN PSORIASIS AND CORONARY ARTERY DISEASE: THE ROLE OF OXIDATIVE STRESS AND INFLAMMATION (2015) (1)
- Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients (2022) (1)
- Diet and Exercise for Obese Patients With Heart Failure. (2016) (1)
- Exercise Testing in Coronary Heart Disease (2007) (1)
- Levosimendan in the treatment of AHF: lessons from surveys and clinical trials (2008) (1)
- Abstract 2367: Effects of Recombinant Human Erythropoietin on Left Ventricular Diastolic and Systolic Function, and Plasma Biomarkers of Neurohormonal Activation in Patients with Chronic Heart Failure and Anemia (2006) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Copper serum levels in patients with heart failure correlate with parameters of left ventricular systolic and diastolic dysfunction (2013) (1)
- Estrogen administration in patients with chronic heart failure: not ready for prime time (2003) (1)
- Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use. (2020) (1)
- Long-term prognostic value of diastolic exercise echocardiography. (2013) (1)
- The antioxidant effects of granulocyte colony-stimulating factor (2009) (1)
- Abstract 812: Renal Function And Acute Heart Failure: A Substudy From Alarm-hf (2008) (1)
- 509 The role of left ventricular long axis contraction in patients with asymptomatic aortic regurgitation (2005) (1)
- Physical training-induced reduction of peripheral monocyte-related inflammatory markers is associated with improvement in endothelial function of chronic heart failure patients (2003) (1)
- Gene Therapy in the Management of Cardiovascular Disease (2003) (1)
- P2522The combined treatment with glucagon like peptide-1 analogues and sodium-glucose co-transporter 2 causes a greater improvement of arterial stiffness than each treatment alone in type 2 diabetes (2018) (1)
- 586 Right ventricular tissue Doppler imaging as a prognostic marker in advanced heart failure (2007) (1)
- 324 NT‐pro BNP is a better biomarker than BNP for the identification of left ventricular dysfunction in beta‐thalassemia major patients (2008) (1)
- Increased serum levels of granulocyte-macrophage colony-stimulating factor in hypercholesterolemic patients (1999) (1)
- Acute Heart Failure Syndromes in β-Thalassemia (2008) (1)
- Association of ventricular–arterial interaction with the response to cardiac resynchronization therapy (2021) (1)
- Serum profiles of C-C chemokines in hypertensive patients with or without significant hyperlipidemia (1999) (1)
- Effects of hormone replacement therapy on endothelial function, arterial stiffness and myocardial deformation in women with Turner syndrome (2021) (1)
- Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study (2021) (1)
- Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis (2022) (1)
- Effects of Growth Hormone Administration on Plasma Levels of Proinflammatory Cytokines and Soluble Apoptosis Mediators Fas/FasLigand in Patients with Dilated Cardiomyopathy (2002) (1)
- Macrophage chemoattractant protein-1 and macrophage inflammatory protein-1α serum profiles in hypertensive patients with or without significant hyperlipidemia (2000) (1)
- Poster Session 2The imaging examination and quality assessment. (2016) (0)
- 158 Growth hormone treatment reduces circulating inflammatory cytokines and improves left ventricular contractile performance in patients with dilated cardiomyopathy (2003) (0)
- Levosimendan, Compared to Dobutamine, Reduces Enzymatic Markers Associated with Liver Congestion and Right Heart Failure: A SURVIVE Subanalysis (2007) (0)
- 810-2 Effects of growth hormone on circulating cytokine dysbalance and left ventricular geometry in patients with idiopathic dilated cardiomyopathy (2004) (0)
- Increased levels of cystatin-c are associated with hyponatremia in acutely decompensated heart failure patients with renal dysfunction (2013) (0)
- HEART FAILURE VIENNA 2018 prEVEntion & trEatMEnt aCutE HEart FailurE : WHat iS nEW ? (2018) (0)
- A novel strategy for the management of lung congestion: targeting TRPV4 channel, the ‘gate keeper’ of pulmonary capillary permeability (2020) (0)
- Effects of heat-not-burn compared to combustible cigarettes on coronary flow, myocardial work index and vascular function (2021) (0)
- Atheromatous Plaques in the Descending Aorta and the Risk of Stroke: A Systematic Review and Meta-Analysis” to the Editor (0)
- Abstract 2703: Clinical and neurohormonal correlates and prognostic value of Kansas City Cardiomyopathy Questionnaire in patients with chronic heart failure (2006) (0)
- P301Preserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation (2019) (0)
- 662 Darbepoetin‐alfa reduces plasma interleukin‐6 and C‐reactive protein and improves quality of life in patients with chronic heart failure and anemia (2007) (0)
- Abstract 3568: Combined Prognostic Value of Tissue Doppler Right Ventricular Systolic and Diastolic Function Indices and Plasma B-Type Natriuretic Peptide in Patients With Advanced Heart Failure (2009) (0)
- Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes (2020) (0)
- Left atrial deformation in heart failure: a clinical update. (2022) (0)
- Extracorporeal life support at the Emergency Department: new insights into the management of acute cardiac care patients. (2021) (0)
- A national survey on heart failure structures and management (2013) (0)
- Levosimendan therapy in decompensated chronic heart failure : Effects on natriuretic peptides and hemodynanic parameters (2005) (0)
- 414 Ventricular-arterial interaction predicts response to cardiac resynchronization therapy: a link with improvement of endothelial function and arterial elastic properties (2020) (0)
- Vaccination in Patients With Heart Disease. How Long Should We Wait? Response. (2019) (0)
- Gamma GT value on admission predicts in-hospital worsening of renal function in acute heart failure patients (2013) (0)
- P709Improvement in endothelial function and arterial elastic properties facilitates response to cardiac resynchronization therapy (2019) (0)
- Levosimendan: a decade of experience in Europe built on years of evidence (2008) (0)
- 547 Nt-pro-BNP plasma levels are associated with temporal changes of early colour M-Mode flow propagation after aortic valve replacement (2005) (0)
- Estimating prognosis: prognostic scores (2018) (0)
- 528 Effects of recombinant human erythropoietin on left ventricular diastolic and systolic function, and plasma biomarkers of neurohormonal activation in patients with chronic heart failure and anaemia (2006) (0)
- Effects of glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors on myocardial deformation and work index in type 2 diabetes: 1 year follow up (2021) (0)
- 1115 BNP as a tool for the assessment of pulmonary capillary wedge pressure in patients with systolic heart failure and a non predictive mitral E/Ea ratio (2006) (0)
- 1058 Evaluation of ventricular long axis contraction in patients with asymptomatic non-ischemic mitral valve regurgitation and normal systolic function (2006) (0)
- Serum profiles of proinflammatory cytokines and their soluble receptors according to the severity of acute myocardial infarction (1998) (0)
- Abstract 9118: Inhibition Of Interleukin-1 Activity By Anakinra Improves Endothelial, Coronary And Aortic Function In Patients With CAD And Coexistent Rheumatoid Arthritis By Reducing Apoptosis And Oxidative Stress (2012) (0)
- Arterial wall stiffness in patients with abdominal aortic aneurysms and concomitant coronary artery disease (2020) (0)
- Detection of microsatellite alterations in sporadic cardiac myxomas (1998) (0)
- 546 Clinical and neurohormonal correlates of circulating soluble apoptosis markers in decompensated advanced heart failure (2003) (0)
- HYPONATREMIA AND ITS MANAGEMENT IN PATIENTS WITH HEART FAILURE (2008) (0)
- Effects of growth hormone treatment on circulating proinflammatory cytokines and soluble apoptosis receptor Fas in patients with dilated cardiomyopathy (2000) (0)
- Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients (2022) (0)
- Abstract 2947: Effects of Serial Levosimendan Infusions on Left Ventricular Remodeling and Plasma Biomarkers of Myocardial Injury and Neurohormonal Activation in Patients with Advanced Heart Failure (2006) (0)
- Abstract 105: Percutaneous Patent Foramen Ovale Closure for the Secondary Prevention of Cryptogenic Cerebral Ischemia: A Network Meta-Analysis (2018) (0)
- Pregnancy in a Patient With Tetralogy of Fallot and Borderline Pulmonary Arterial Hypertension (2020) (0)
- Frequency and prognostic significance of hypoalbuminemia in cardiogenic shock (2018) (0)
- Abstract 1532: Combined Prognostic Value Of Self-rating Depression Scores And Plasma B-type Natriuretic Peptide In Hospitalized Patients With Chronic Heart Failure (2007) (0)
- Frontiers in Heart Failure: Clinical Issues (2016) (0)
- Cardiovascular prevention in diabetes mellitus: no magic remedies. (2014) (0)
- 787 Circulating pro‐inflammatory cytokines and soluble apoptosis mediators are associated with depressive symptoms of patients with chronic heart failure (2005) (0)
- Abstract 37: Novel Oral Anticoagulants for the Secondary Prevention of Cerebral Ischemia: A Network Meta-analysis (2016) (0)
- Phenotyping heart failure with preserved ejection fraction by echocardiography: a light in the tunnel? (2017) (0)
- Heart failure / cardiomyopathy Liver function abnormalities , clinical profile , and outcome in acute decompensated heart failure (2013) (0)
- Letter to the Editor Giant unruptured aneurysm of right valsalva sinus detected by magnetic resonance imaging (2004) (0)
- 1037 Evaluation of ventricular long axis contraction for outcome prediction in asymptomatic aortic regurgitation. A prospective 12-month follow-up study (2006) (0)
- 458 Aldosterone antagonism reduces circulating interleukin‐6 and soluble intercellular adhesion molecule‐1 in patients with advanced chronic heart failure (2004) (0)
- 736 Effects of levosimendan on plasma markers of oxidative and nitrosative stress, and cyclic GMP in patients with advanced heart failure (2008) (0)
- Association of LpPLA2 activity with coronary and LV function in patients with coronary artery disease and coexistent rheumatoid arthritis: effects of Interleukin-1 inhibition (2013) (0)
- 4917Global longitudinal strain to pulse wave velocity ratio (VA coupling) is a better indicator of target organ damage than the arterial elastance to LV elastance ratio in hypertensives (2018) (0)
- 1070 Increase of coronary flow after levosimendan infusion is associated with improvement in cardiac performance in patients with decompensated heart failure (2006) (0)
- 352 Kansas City Cardiomyopathy Questionnaire is associated with immune and neurohormonal activation and predicts long‐term outcome in outpatients with chronic heart failure (2008) (0)
- Anti-cytokine therapies in chronic heart failure: is this concept still alive? (2005) (0)
- 405 Serum profiles of matrix metalloproteinases and their inhibitor in patients with acute decompensation of chronic heart failure and left ventricular hypertrophy or dilatation (2003) (0)
- Abstract TP218: Transoesophageal Echocardiography in the Diagnostic Work-up of Patients With Embolic Stroke of Undetermined Source: A Necessary Investigation That Should Not Be Overlooked (2016) (0)
- Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes (2020) (0)
- 559 A novel therapy for patients with unresectable pancreatic carcinoma (1995) (0)
- TREATMENT WITH ANTI-IL12/23 AGENTS IMPROVES FETUIN AND OXIDATIVE STRESS IN PARALLEL WITH ENDOTHELIAL GLYCOCALYX, CORONARY FUNCTION AND MYOCARDIAL TWISTING IN PATIENTS WITH PSORIASIS (2015) (0)
- Functional electrical stimulation of lower limbs improves clinical status and endothelial function in heart failure with preserved left ventricular ejection fraction (2013) (0)
- Clinical relevance of circulating monocyte‐endothelial cell adhesive interaction markers in advanced heart failure (2000) (0)
- Chronic evidence-based heart failure medications beneficially affect in-hospital prognosis in patients with acute heart failure and concomitant chronic obstructive pulmonary disease (2013) (0)
- Response to Editor: (2007) (0)
- P5611Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction and abnormal myocardial deformation in untreated hypertensive patients (2018) (0)
- 102 Effects of Darbepoetin‐alpha on quality of life and emotional stress in anemic patients with chronic heart failure (2008) (0)
- 2234Long-term antihypertensive treatment improves left ventricular torsional deformation parameters along with vascular parameters in hypertensives: a 3 year follow-up study (2018) (0)
- 546 Plasma levels of peripheral inflammatory markers are associated with the regression of left ventricular stiffness after valve replacement for aortic stenosis (2005) (0)
- Abstract 4373: Effects of Darbepoetin-Alpha on Plasma Markers of Oxidative and Nitrosative Stress in Anemic Patients with Chronic Heart Failure (2008) (0)
- Update : Acute Heart Failure ( I ) Acute Heart Failure : Epidemiology , Risk Factors , and Prevention (2019) (0)
- Abstract 77: Intensity of Blood Pressure Reduction and Secondary Stroke Prevention: A Systematic Review and Meta-regression Analysis of Randomized Clinical Trials (2017) (0)
- Immunomodulatory effects of growth hormone administration are associated with improvement in myocardial contractile performance in dilated cardiomyopathy patients (2003) (0)
- ESC guidelines implementation in primary care patients with heart failure: focus on uptitration of life saving medications (2013) (0)
- Differences in coronary flow reserve and flow-mediated dilation between plaque psoriasis and psoriatic arthritis (2022) (0)
- Clinical correlates and prognostic value of Duke's Activity Status Index in chronic heart failure (2008) (0)
- HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Association: The HERMES‐HF Registry (2020) (0)
- Body mass index and disease-modifying therapy in acute heart failure patients (2013) (0)
- Abstract 5915: Clinical and Neurohormonal Correlates and Prognostic Value of Serum Prolactin Levels in Patients with Chronic Heart Failure (2008) (0)
- Endothelial glycocalyx integrity and microvascular perfusion are associated with novel echocardiographic markers and carotid intima-media thickness in patients with psoriasis (2021) (0)
- P5456Comparison of the Echo-derived markers of arterial stiffness to pulse wave velocity for the prediction of impaired LV function and coronary flow reserve in hypertensive patients (2017) (0)
- Increased levels of granulocyte macrophage colony stimulating factor in hypercholesterolemic patients (1999) (0)
- 95 Additive prognostic value of self-rating depression scores and plasma B-type natriuretic peptide in chronic heart failure (2007) (0)
- Advanced End-Stage Heart Failure: Epidemiology and Management (2016) (0)
- 391 Uric acid blood levels are associated with clinical and echocardiographic parameters of chronic heart failure (2003) (0)
- Rate of intramyocardial NCAM re-expression in dilated cardiomyopathy: More pronounced in the left than in the right ventricle? (2017) (0)
- The additive predictive value of arterial stiffness for outcome to endothelial glycocalyx and SCORE in middle age individuals: 6 years follow-up (2022) (0)
- 485 Differences in serum activity of matrix metalloproteinases between diabetic and non-diabetic patients with chronic heart failure (2003) (0)
- Association of endothelial glycocalyx integrity and microvascular perfusion with novel echocardiographic markers and carotid intima-media thickness in patients with psoriasis (2021) (0)
- Contents Vol. 121, 2012 (2012) (0)
- 780 Levosimendan improves endothelial function and reduces soluble adhesion molecule levels in patients with advanced heart failure (2007) (0)
- Prognostic implications of physical activity and health status related questionnaires in adult patients with congenital heart disease (2013) (0)
- Abstract 2229: The Prognostic Power of Inflammatory Markers in Predicting Lone Atrial Fibrillation Recurrence (2006) (0)
- Clinical relevance of functional and depressive scores in patients with chronic heart failure (2006) (0)
- Abstract 2945: Increase of Coronary Flow After Levosimendan Infusion is Associated with Improvement in Cardiac Performance in Patients with Decompensated Heart Failure (2006) (0)
- Poster session III * Friday 10 December 2010, 08:30-12:30 (2010) (0)
- 761 Echocardiographic characteristics and brain natriuretic peptide levels in cor pulmonale patients (2008) (0)
- Biologics improve endothelial, vascular and left ventricular myocardial function in patients with psoriatic arthritis (2022) (0)
- Darbepoetin alfa in systolic heart failure. (2013) (0)
- Abstract 3894: Clinical Presentation and Predictors of In-hospital Mortality in Acute Heart Failure Patients With Preserved Left Ventricular Ejection Fraction: The ALARM Registry (2009) (0)
- Abstract 12495: Body Mass Index and In-Hospital Mortality in Acute Heart Failure Patients (2012) (0)
- Rapid fire ‐Clinical 1 (2014) (0)
- Chapter-12 Adrenomedullin (2012) (0)
- Acute Heart Failure (2018) (0)
- Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment (2020) (0)
- 124 Depression is associated with enhanced neurohormonal and inflammatory activation, and worse prognosis in patients with chronic heart failure (2006) (0)
- Chapter-16 When and How to Use Inotropes? (2014) (0)
- Application of molecular biology techniques to the study of cardiac myxomas: Review and perspectives (1995) (0)
- 650 Effects of levosimendan on quality of life and emotional stress in patients with advanced heart failure (2007) (0)
- Abstract 1336: Selective Serotonin Reuptake Inhibition Reduces Circulating Markers of Oxidative Stress in Depressed Patients With Chronic Heart Failure (2009) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Blood pressure measurement and arterial stiffness / Endothelial function and the microcirculation 51 (0)
- Invited commentary Prognostic value of QRS duration and ejection fraction: going back to the roots (2008) (0)
- 382 Levosimendan improves markers of diastolic function and neurohormonal activation in patients with decompensated advanced heart failure (2006) (0)
- Abstract 96: Efficacy and Safety of Oral Anticoagulants in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis (2019) (0)
- 306 Clinical and neurohormonal correlates of Dual Energy X‐Ray Absorbtiometry (DEXA) body fat indices in patients with heart failure (2008) (0)
- Echocardiographic correlates and prognostic value of soluble apoptosis‐signaling molecules in patients with congestive heart failure (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John T. Parissis?
John T. Parissis is affiliated with the following schools:
